You searched for "stutter"
Screening: evaluating the outcomes of early intervention
Newborn hearing screening is now the accepted standard of care in several countries, and is becoming increasingly more established worldwide. White [1] reported eight countries screening over 90% of newborns, ten screening between 25-89% of births and a further 54...Hearing in middle-age: hearing impairment, tinnitus and hearing aid use in UK adults
Hearing loss has a well-documented adverse impact on emotional, social and physical well-being. In this article, Dr Piers Dawes from the University of Manchester gives an insight into his team’s recent work analysing the very large UK Biobank data set,...Hidden hearing loss in humans
Awareness of cochlear synaptopathy (‘hidden hearing loss’) is growing. Chris Plack gives us an introduction to the condition, defining it and reviewing recent research in humans and animals with respect to noise exposure. The main cause of hearing loss is...The new (digital) face of BIOHIT HealthCare
BIOHIT HealthCare is pleased to announce the launch of its new website, which is designed to make it easier than ever for healthcare professionals to find the information they need.Landmark study at Homerton University Hospital confirms GastroPanel®’s diagnostic accuracy
BIOHIT HealthCare is pleased to announce that a clinical study conducted by Homerton University Hospital NHS Foundation Trust, London, has confirmed the diagnostic accuracy of GastroPanel in identifying gastric cancer risk in patients with upper abdominal complaints. This study demonstrated...Balance and fall prevention in individuals with hearing impairments: clinical insights
Exploring how hearing loss heightens fall risk and how integrated audiologic, vestibular and technological strategies can transform balance care and prevention. Hearing impairment is one of the most common chronic health conditions worldwide, affecting an estimated 466 million people according...Thyroid cancer – the last decade
Professor Ashok Shaha describes the evolution in the treatment of thyroid cancer that he has witnessed over the last decade and the invaluable progress made by himself and others, from their contributions to staging systems and guidelines. Nuances and paradigm...
